Search

everythinglearnresearchcommunity

for

Search:↓

Reflectance confocal microscopy confirms that yellow dots are signs of damaged hair follicles in alopecia areata.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

Careful planning and accurate diagnosis are crucial for successful hair restoration surgery.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

Frontal fibrosing alopecia and androgenetic alopecia may be related, with a possible shared cause.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Minoxidil and finasteride treat hair loss; more research needed for other options.

Certain groups may need vitamin supplements to improve hair health and prevent other health problems.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

Some chemotherapy can cause permanent hair loss.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Dermoscopy is useful for diagnosing various skin, hair, and nail disorders and can reduce the need for biopsies.

A woman with dermatomyositis showed rare skin symptoms, was treated successfully, and her case suggests checking for cancer in similar patients.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Cyclosporine A can reduce inflammation in dogs with sebaceous adenitis, but ongoing treatment is needed.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

Minoxidil promotes hair regrowth, but more research needed for effectiveness and response factors.

Hair transplants can lead to hair loss from lichen planopilaris, and patients should be tested and wait two years before the procedure.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.